174
Participants
Start Date
September 18, 2024
Primary Completion Date
February 14, 2028
Study Completion Date
February 14, 2028
AZD5492
CD8/TCR based T-cell engaging antibody targeting CD20, which is administered subcutaneously
RECRUITING
Research Site, København Ø
RECRUITING
Research Site, Melbourne
RECRUITING
Research Site, Nedlands
RECRUITING
Research Site, New York
RECRUITING
Research Site, New York
RECRUITING
Research Site, Milan
RECRUITING
Research Site, Winston-Salem
RECRUITING
Research Site, Madrid
RECRUITING
Research Site, Charlotte
RECRUITING
Research Site, Pessac
RECRUITING
Research Site, Bologna
RECRUITING
Research Site, Houston
RECRUITING
Research Site, München
RECRUITING
Research Site, Ulm
RECRUITING
Research Site, La Jolla
NOT_YET_RECRUITING
Research Site, Villejuif
RECRUITING
Research Site, Würzburg
RECRUITING
Research Site, Seattle
RECRUITING
Research Site, Shanghai
RECRUITING
Research Site, Hangzhou
WITHDRAWN
Research Site, Boston
RECRUITING
Research Site, Hackensack
RECRUITING
Research Site, Calgary
RECRUITING
Research Site, Toronto
RECRUITING
Research Site, Montreal
RECRUITING
Research Site, Chūōku
RECRUITING
Research Site, Kashiwa
RECRUITING
Research Site, Barcelona
RECRUITING
Research Site, L'Hospitalet de Llobregat
Lead Sponsor
AstraZeneca
INDUSTRY